RaySearch Laboratories AB acquired product line Druglog of Pharmacolog AB for SEK 7 million. - Marketscreener.com
P750 Stock | 0.55 0.04 6.78% |
Roughly 62% of PHARMACOLOG's investor base is looking to short. The analysis of current outlook of investing in PHARMACOLOG I UPPSALA suggests that many traders are alarmed regarding PHARMACOLOG's prospects. The current market sentiment, together with PHARMACOLOG's historical and current headlines, can help investors time the market. In addition, many technical investors use PHARMACOLOG I UPPSALA stock news signals to limit their universe of possible portfolio assets.
PHARMACOLOG stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of PHARMACOLOG daily returns and investor perception about the current price of PHARMACOLOG I UPPSALA as well as its diversification or hedging effects on your existing portfolios.
PHARMACOLOG |
RaySearch Laboratories AB acquired product line Druglog of Pharmacolog AB for SEK 7 million. Marketscreener.com
Read at news.google.com
PHARMACOLOG I UPPSALA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PHARMACOLOG stock to make a market-neutral strategy. Peer analysis of PHARMACOLOG could also be used in its relative valuation, which is a method of valuing PHARMACOLOG by comparing valuation metrics with similar companies.
Peers
PHARMACOLOG Related Equities
TSFA | Taiwan Semiconductor | 1.45 | ||||
RKET | Rocket Internet | 1.28 | ||||
ELG | Elmos Semiconductor | 1.00 | ||||
SMG | Magnachip Semiconductor | 0.52 | ||||
BAC | Bank of America | 0.29 | ||||
CAC1 | Casio Computer | 0.25 | ||||
1CG | CRISPR Therapeutics | 0.00 | ||||
CQD | Charter Communications | 3.52 |
Complementary Tools for PHARMACOLOG Stock analysis
When running PHARMACOLOG's price analysis, check to measure PHARMACOLOG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMACOLOG is operating at the current time. Most of PHARMACOLOG's value examination focuses on studying past and present price action to predict the probability of PHARMACOLOG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PHARMACOLOG's price. Additionally, you may evaluate how the addition of PHARMACOLOG to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |